Aggressive digital papillary adenocarcinoma: a review
Summary Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness a...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental dermatology 2010-03, Vol.35 (2), p.113-119 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 119 |
---|---|
container_issue | 2 |
container_start_page | 113 |
container_title | Clinical and experimental dermatology |
container_volume | 35 |
creator | Hsu, H.-C. Ho, C.-Y. Chen, C.-H. Yang, C.-H. Hong, H.-S. Chuang, Y.-H. |
description | Summary
Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers. |
doi_str_mv | 10.1111/j.1365-2230.2009.03490.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733955244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733955244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</originalsourceid><addsrcrecordid>eNqNkF1v0zAUhi0EYmXwF1AkhLhK8NeJbSQuRtnGxwAhhri0HOekckmTYrdb9-9xaFUkrvCNLfl5fV4_hBSMViyvl8uKiRpKzgWtOKWmokIaWu3ukdnx4j6ZUUFVWRuhT8ijlJaUMsEUPCQnzGglBYcZgbPFImJK4QaLNizCxvXF2q1D37t4V7gWh9G76MMwrtyrwhURbwLePiYPOtcnfHLYT8n3i_Pr-bvy6svl-_nZVemBSVo6DUoq6KjxTjChFKu5RupECw5BYaNq33UaTQONpxrBmEZwAVzXbU1RiVPyYv_uOo6_tpg2dhWSx1xuwHGbrBLCAHApM_nsH3I5buOQy1kGEjTjxkyU3lM-jilF7Ow6hlX-qWXUTmbt0k4C7STQTmbtH7N2l6NPDwO2zQrbv8GDygw8PwAuedd30Q0-pCPHuaTGcJO513vuNvR4998F7Pz87XTK-XKfD2mDu2PexZ-2VkKB_fH50n6VF9cfP314Y7-J3-h2oNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1545812994</pqid></control><display><type>article</type><title>Aggressive digital papillary adenocarcinoma: a review</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Hsu, H.-C. ; Ho, C.-Y. ; Chen, C.-H. ; Yang, C.-H. ; Hong, H.-S. ; Chuang, Y.-H.</creator><creatorcontrib>Hsu, H.-C. ; Ho, C.-Y. ; Chen, C.-H. ; Yang, C.-H. ; Hong, H.-S. ; Chuang, Y.-H.</creatorcontrib><description>Summary
Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers.</description><identifier>ISSN: 0307-6938</identifier><identifier>EISSN: 1365-2230</identifier><identifier>DOI: 10.1111/j.1365-2230.2009.03490.x</identifier><identifier>PMID: 19874325</identifier><identifier>CODEN: CEDEDE</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenocarcinoma, Papillary - pathology ; Adenocarcinoma, Papillary - surgery ; Amputation ; Biological and medical sciences ; Dermatology ; Fingers - surgery ; Humans ; Medical sciences ; Skin Neoplasms - pathology ; Skin Neoplasms - surgery ; Time Factors ; Toes - surgery</subject><ispartof>Clinical and experimental dermatology, 2010-03, Vol.35 (2), p.113-119</ispartof><rights>2009 The Author(s). Journal compilation © 2009 British Association of Dermatologists</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</citedby><cites>FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22409929$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19874325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hsu, H.-C.</creatorcontrib><creatorcontrib>Ho, C.-Y.</creatorcontrib><creatorcontrib>Chen, C.-H.</creatorcontrib><creatorcontrib>Yang, C.-H.</creatorcontrib><creatorcontrib>Hong, H.-S.</creatorcontrib><creatorcontrib>Chuang, Y.-H.</creatorcontrib><title>Aggressive digital papillary adenocarcinoma: a review</title><title>Clinical and experimental dermatology</title><addtitle>Clin Exp Dermatol</addtitle><description>Summary
Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers.</description><subject>Adenocarcinoma, Papillary - pathology</subject><subject>Adenocarcinoma, Papillary - surgery</subject><subject>Amputation</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>Fingers - surgery</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Skin Neoplasms - pathology</subject><subject>Skin Neoplasms - surgery</subject><subject>Time Factors</subject><subject>Toes - surgery</subject><issn>0307-6938</issn><issn>1365-2230</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1v0zAUhi0EYmXwF1AkhLhK8NeJbSQuRtnGxwAhhri0HOekckmTYrdb9-9xaFUkrvCNLfl5fV4_hBSMViyvl8uKiRpKzgWtOKWmokIaWu3ukdnx4j6ZUUFVWRuhT8ijlJaUMsEUPCQnzGglBYcZgbPFImJK4QaLNizCxvXF2q1D37t4V7gWh9G76MMwrtyrwhURbwLePiYPOtcnfHLYT8n3i_Pr-bvy6svl-_nZVemBSVo6DUoq6KjxTjChFKu5RupECw5BYaNq33UaTQONpxrBmEZwAVzXbU1RiVPyYv_uOo6_tpg2dhWSx1xuwHGbrBLCAHApM_nsH3I5buOQy1kGEjTjxkyU3lM-jilF7Ow6hlX-qWXUTmbt0k4C7STQTmbtH7N2l6NPDwO2zQrbv8GDygw8PwAuedd30Q0-pCPHuaTGcJO513vuNvR4998F7Pz87XTK-XKfD2mDu2PexZ-2VkKB_fH50n6VF9cfP314Y7-J3-h2oNA</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Hsu, H.-C.</creator><creator>Ho, C.-Y.</creator><creator>Chen, C.-H.</creator><creator>Yang, C.-H.</creator><creator>Hong, H.-S.</creator><creator>Chuang, Y.-H.</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201003</creationdate><title>Aggressive digital papillary adenocarcinoma: a review</title><author>Hsu, H.-C. ; Ho, C.-Y. ; Chen, C.-H. ; Yang, C.-H. ; Hong, H.-S. ; Chuang, Y.-H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adenocarcinoma, Papillary - pathology</topic><topic>Adenocarcinoma, Papillary - surgery</topic><topic>Amputation</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>Fingers - surgery</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Skin Neoplasms - pathology</topic><topic>Skin Neoplasms - surgery</topic><topic>Time Factors</topic><topic>Toes - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hsu, H.-C.</creatorcontrib><creatorcontrib>Ho, C.-Y.</creatorcontrib><creatorcontrib>Chen, C.-H.</creatorcontrib><creatorcontrib>Yang, C.-H.</creatorcontrib><creatorcontrib>Hong, H.-S.</creatorcontrib><creatorcontrib>Chuang, Y.-H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hsu, H.-C.</au><au>Ho, C.-Y.</au><au>Chen, C.-H.</au><au>Yang, C.-H.</au><au>Hong, H.-S.</au><au>Chuang, Y.-H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aggressive digital papillary adenocarcinoma: a review</atitle><jtitle>Clinical and experimental dermatology</jtitle><addtitle>Clin Exp Dermatol</addtitle><date>2010-03</date><risdate>2010</risdate><volume>35</volume><issue>2</issue><spage>113</spage><epage>119</epage><pages>113-119</pages><issn>0307-6938</issn><eissn>1365-2230</eissn><coden>CEDEDE</coden><abstract>Summary
Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19874325</pmid><doi>10.1111/j.1365-2230.2009.03490.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0307-6938 |
ispartof | Clinical and experimental dermatology, 2010-03, Vol.35 (2), p.113-119 |
issn | 0307-6938 1365-2230 |
language | eng |
recordid | cdi_proquest_miscellaneous_733955244 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
subjects | Adenocarcinoma, Papillary - pathology Adenocarcinoma, Papillary - surgery Amputation Biological and medical sciences Dermatology Fingers - surgery Humans Medical sciences Skin Neoplasms - pathology Skin Neoplasms - surgery Time Factors Toes - surgery |
title | Aggressive digital papillary adenocarcinoma: a review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T14%3A33%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aggressive%20digital%20papillary%20adenocarcinoma:%20a%20review&rft.jtitle=Clinical%20and%20experimental%20dermatology&rft.au=Hsu,%20H.-C.&rft.date=2010-03&rft.volume=35&rft.issue=2&rft.spage=113&rft.epage=119&rft.pages=113-119&rft.issn=0307-6938&rft.eissn=1365-2230&rft.coden=CEDEDE&rft_id=info:doi/10.1111/j.1365-2230.2009.03490.x&rft_dat=%3Cproquest_cross%3E733955244%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1545812994&rft_id=info:pmid/19874325&rfr_iscdi=true |